Valuation: Treace Medical Concepts, Inc.

Capitalization 493M 466M 433M 386M 697M 41.87B 763M 5.38B 1.99B 17.18B 1.85B 1.81B 74.52B P/E ratio 2024 *
-8.56x
P/E ratio 2025 * -10.5x
Enterprise value 456M 431M 400M 357M 644M 38.69B 705M 4.97B 1.83B 15.88B 1.71B 1.67B 68.87B EV / Sales 2024 *
2.2x
EV / Sales 2025 * 2.09x
Free-Float
-
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.13%
1 week-9.79%
Current month-7.04%
1 month-1.49%
3 months+52.60%
6 months+34.01%
Current year-37.88%
More quotes
1 week
7.64
Extreme 7.64
8.65
1 month
7.21
Extreme 7.21
8.83
Current year
3.92
Extreme 3.92
15.98
1 year
3.92
Extreme 3.92
15.98
3 years
3.92
Extreme 3.92
27.97
5 years
3.92
Extreme 3.92
37.17
10 years
3.92
Extreme 3.92
37.17
More quotes
Director TitleAgeSince
Chief Executive Officer 52 2013-12-31
Director of Finance/CFO 54 2020-08-31
Chief Operating Officer - -
Manager TitleAgeSince
Director/Board Member 52 2013-12-31
Chairman 77 2014-06-30
Director/Board Member 65 2015-02-28
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.13%-9.79%-16.63%-54.61%494M
-0.01%+0.01%+92.19%+84.13%12.57B
+1.53%-1.63%+7.51%-3.57%9.1B
-0.16%-1.26%+62.44%-38.75%9.09B
-2.99%+2.62%+41.29%+72.98%5.12B
+0.10%-1.13%-5.74%+4.29%4.78B
-1.30%-2.51%+0.21%-3.63%4.67B
+1.55%+1.05%-25.04%-55.40%4.27B
+2.47%-4.02%+129.20%-67.36%3.03B
+4.52%+2.44%-15.32%-33.29%2.99B
Average +0.56%-1.42%+27.01%-9.52% 5.61B
Weighted average by Cap. +0.34%-0.64%+39.37%+8.60%
See all sector performances

Financials

2024 *2025 *
Net sales 208M 196M 182M 162M 293M 17.61B 321M 2.26B 835M 7.23B 779M 762M 31.34B 225M 213M 197M 176M 318M 19.09B 348M 2.45B 906M 7.83B 845M 827M 33.98B
Net income -57.09M -53.96M -50.06M -44.64M -80.63M -4.84B -88.33M -622M -230M -1.99B -214M -210M -8.62B -47.73M -45.11M -41.85M -37.32M -67.4M -4.05B -73.84M -520M -192M -1.66B -179M -175M -7.21B
Net Debt -37.42M -35.37M -32.81M -29.26M -52.84M -3.18B -57.89M -408M -151M -1.3B -141M -137M -5.65B -24.09M -22.77M -21.13M -18.84M -34.02M -2.04B -37.28M -263M -96.95M -839M -90.47M -88.5M -3.64B
More financial data * Estimated data
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Employees
516
More about the company
Date Price Change Volume
24-12-09 7.920 $ -0.13% 170,258
24-12-06 7.930 $ +2.32% 201,870
24-12-05 7.750 $ -3.85% 295,916
24-12-04 8.060 $ -5.73% 453,498
24-12-03 8.550 $ -2.62% 354,547

Delayed Quote Nasdaq, December 09, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C-
surperformance-ratings-light-chart TREACE-MEDICAL-CONCEPTS-IMore Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
7.920USD
Average target price
7.500USD
Spread / Average Target
-5.30%
Consensus

Quarterly revenue - Rate of surprise